Charles Ornstein

The Trump administration told hospitals to stop reporting data to the CDC, and report it to HHS instead. Vice President Mike Pence said the information would continue to be released publicly. It hasn’t worked out as promised.

Faced with competition, some pharmaceutical companies are cutting deals with insurance companies to favor their brand-name products over cheaper generics. Insurers pay less, but sometimes consumers pay more.

A trove of documents published as part of a legal settlement offers an unvarnished look inside the financial relationships between pharmaceutical companies and the medical community — from the perspective of drug companies themselves.

Texas agencies have fought against releasing records that could help clarify the response to the Uvalde school shooting. The blanket denials are reminiscent of another tragic case one reporter covered years ago.

A patient privacy law known as HIPAA, passed in 1996, hasn’t kept pace with new technologies and at-home tests.

A patient privacy law known as HIPAA, passed in 1996, hasn’t kept pace with new technologies and at-home tests.

Dr. Gerald M. Sacks, who was named in a 2010 ProPublica investigation, will pay more than $270,000 to resolve allegations of taking kickbacks, though he denies taking them.

Getting our investigation’s findings to the people we write about is just as important as reaching a large audience. Consider these two examples.

Impact in accountability journalism is unpredictable. Here’s how ProPublica’s recent articles have prompted change in the world.

After publishing a story on a doctor accused of violating federal research rules and skirting ethical guidelines, ProPublica’s Charles Ornstein was named in a libel suit. An appeals court recently dismissed the case, but the experience took a toll.